$APYP AppYea Launches Smart Biofeedback-Based Wristband to

New Post Public Reply Private Reply Replies (0) Message Board
energy_wave
148
$APYP AppYea Launches Smart Biofeedback-Based Wristband to Address Snoring

Quote:
PR Newswire

NEW YORK, Sept. 30, 2024

Wristband connects to an app on iPhone or Android to detect snoring and activates gentle vibrations, prompting users to change their sleeping position

NEW YORK, Sept. 30, 2024 /PRNewswire/ -- AppYea Inc. (OTCQB: APYP), developer of an innovative wearable solution to monitor sleep apnea and snoring, today announced the launch of the new AppySleep device. AppySleep is the first product to leverage AI for optimal customization of snoring treatment and can also detect irregular breathing patterns.

QRCODE_AppySleep.jpg

At this stage of the launch, the app can be downloaded for free. However, using the app requires purchasing the accompanying wristband, available at the company's store (www.appysleep.com) or on Amazon for an introductory price of $149. The wristband is delivered to U.S. customers within 72 hours.

Customers who purchase AppySleep during the launch will receive a free access to a personal cloud where they can view their sleep history, statistics, personalized graphs, and track improvements in their snoring and overall sleep quality.

In the coming months, the company plans to expand marketing efforts in the U.S. and Canada.

In addition, Appyea is making progress with the development of AppySleep LAB - a touchless app designed for diagnosing sleep apnea without the need for an overnight stay in sleep labs.

The company estimates that it will pre-submit a request to the FDA of AppySleep LAB during H1 2025.

Bary Molchadsky, Chairman of AppYea, commented on the product launch: "Snoring is a common issue, particularly for individuals over the age of 35, yet there have been no comfortable solutions. AppySleep offers an easy-to-use technological solution with an intuitive interface. Our app listens for breathing patterns and, when continuous snoring is detected, activates a gentle vibration in the wristband that encourages users to shift to a side-sleeping position. After several weeks of use, the vibration helps condition users to sleep in the correct position, significantly reducing snoring. The vibration settings can be customized through the app."

Mr. Molchadsky added: "The app provides users with detailed reports and graphs, allowing them to monitor the reduction of snoring over time as well as track other important parameters, including irregular breathing patterns."

The company's online store also offers detailed instructions on how to use the product, along with instructional videos: https://appysleep.com/how-it-works.

Market Overview:

According to Precedence Research, the Sleep Tech Devices Market was valued at USD 21.10 billion in 2023 and is expected to reach USD 113.16 billion by 2033, growing at a CAGR of 18.23% from 2024 to 2033. The wearables segment held the largest market share, approximately 76%, in 2023 and is expected to maintain its dominance throughout the forecast period.
Fior Markets reports that the Global Anti-Snoring Treatment Market is projected to grow from USD 4.3 billion in 2020 to USD 8.6 billion by 2028, reflecting a CAGR of 9.07% during the period from 2021 to 2028.
Fior Markets also estimates that the Global Sleep Apnea Devices Market will reach USD 6.4 billion by 2025.

About AppYea

AppYea is a Healthtech company commercializing innovative wearable technology for the treatment of snoring and developing wearable solutions to diagnose and treat sleep apnea. The Company's solutions are based on its proprietary IP portfolio of AI and sensing technologies for the tracking and analysis of breathing patterns, vital signs, and other physiological parameters during sleep, designed for greater accuracy at lower and affordable cost.

Cautionary Note Regarding Forward-Looking Statements

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of AppYea are subject to many factors including, but not limited to, the sufficiency or working capital and our ability to raise the capital needed to fund our development efforts, the going concern qualification in our financials, timing of product development, the success of the new App, customer acceptance of our products in the market, the introduction of competitive products, the effectiveness of our product distribution networks, the impact of any product liability or other adverse litigation, commercialization and technological difficulties, and the other risks identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission on April 1, 2024, as subsequently supplemented. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.

Contact:
Crescendo Communications, LLC
Tel: (212) 671-1020
Email: APYP@Crescendo-IR.com

Photo - https://mma.prnewswire.com/media/2519232/QRCO...ySleep.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/appyea-launches-smart-biofeedback-based-wristband-to-address-snoring-302262522.html

SOURCE AppYea Inc.


https://www.otcmarkets.com/stock/APYP/news/Ap...?id=454333
big-wave_surfing_01.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Systemair Shakes Things Up: Closing Netherlands Facility

Updated Category News Views 81

Systemair's Shocking Shutdown Decision Feels like we're strapped into a roller coaster with these HVAC companies lately. Systemair (NASDAQ Stockholm: SYSR) sure gave us quite the surprise ride by announcing they're pulling the plug on their production facility in Waalwijk, the Netherlands. This isn't just a ripple in a pond; it's a splash that might make some waves in the...

Continue Reading
Z Squared Eyes 150 MW Expansion at Arkansas Site

Updated Category News Views 23

Turning Power into Potential at Union County Next stop, Union County, Arkansas. Z Squared Inc. (Nasdaq: ZSQR) isn't just talking shop; they're getting down to work. With a freshly acquired site through Paradox Data, LLC, Z Squared's planning to turn vision into reality. The site's already armed with 8 MW of juice, all ready to roll, but their ambitions shoot up to 150 MW...

Continue Reading
OneMain Holdings' Q3 2026: Mixed Signals in Nonprime Sector

Updated Category News Views 35

Third Quarter Earnings: A Double-Edged Sword OneMain Holdings, Inc. (NYSE: OMF) rolled its Q3 2026 numbers out, and they look like a classic cocktail of high hopes and looming risks. On the surface, a diluted EPS of $1.60 might not sound like a knockout punch to the jaw, but let’s not forget they’ve taken a step back from last year’s $1.67. Their net income of $185...

Continue Reading
Cork's Market Power Surges in U.S. Wine Industry

Updated Category News Views 0

Cork: The Unsung Hero of the Wine Bottle You'd think a simple piece of bark couldn't shift the billion-dollar wine industry, but cork closures are doing just that. According to new NielsenIQ data, these natural stoppers are holding their ground as top dogs in the U.S. wine market. Who would've guessed that cork would drive the highest off-premise revenue? That's some...

Continue Reading
Human Judgment Crucial Amid AI Growth in Courts

Updated Category News Views 67

AI in the Justice System: Balancing Potential and Pitfalls You know, when it comes to upholding justice, there's a line between what machines can handle and what only a human can bring to the gavel. Chief Justice Sundaresh Menon of Singapore threw the spotlight on this at an event in Brisbane, hammering home the need for good ole human intuition in the courtroom even as...

Continue Reading
Benewake Unveils SR Series LiDAR for Mobile Robots

Updated Category News Views 34

Wave Goodbye to Bulky Sensors Hot off the Beijing press, Benewake's got something new—the SR Series 360° 3D LiDARs, set to stir up the robotics world. They're compact, power-efficient, and packed with smarts. It seems Benewake is tapping into a juicy market with these little sensors. Sleek Design and Big Promises The SR18 and SR96 models have a lot going for them. The...

Continue Reading
Furniture Quality: Expert Tips for Savvy Shoppers

Updated Category News Views 0

Picking Apart Furniture Quality Before a Purchase In a world where cheap and flashy often overshadow durability, knowing what makes furniture stand the test of time isn't just wise—it's essential. Learn from Nate Bartlett, the furniture sage from Charlevoix, Michigan, who guides shoppers through the maze of quality indicators in a recent HelloNation article. If you're...

Continue Reading
Webull Faces Class Action: Investor Impact Deep Dive

Updated Category News Views 129

What's Going On with Webull? Ah, Webull Corporation, you're in the hot seat now. If you blinked on October 7th, you might have missed a monumental 19.09% cliff dive in Webull's stock, tumbling down to a humble $5.89. The roar wasn't just the market reacting; it was the sonic boom of a class action lawsuit on their heels, alleging some slick legal sledding with misleading...

Continue Reading
OCI Cleared to Merge with Orascom, Sets Delisting Date

Updated Category News Views 53

OCI N.V. has hit a milestone. The shareholders have given the green light to merge with Orascom Construction PLC. This move is fleshed out with an updated roadmap that sharp-eyed investors need to watch closely. The company's shares will no longer be trading on Euronext Amsterdam by late November 2026, contingent on regulatory nods and other variables swirling in the...

Continue Reading
Phrontline's TJ101 Gains Momentum in Cancer Clinical Trials

Updated Category News Views 75

Encouraging Signs from Phrontline's TJ101 ADC Trials In the high-stakes race to outsmart cancer, Phrontline Biopharma is banking on TJ101, their star investigational bispecific antibody-drug conjugate (ADC). The recent results shared at the ESMO Congress 2026 are stirring up quite a bit of chatter. Urothelial Carcinoma and Beyond Now, picture this: six of eight evaluable...

Continue Reading

Top 5 Most Recently Viewed Articles

BridgeBio Pharma Set to Showcase Innovations at Conference

Updated Category News Views 166

BridgeBio Pharma Announces Participation in Key Healthcare Conference BridgeBio Pharma, Inc. (NASDAQ: BBIO), a pioneering biopharmaceutical company committed to genetic disease research, has announced its participation in a major healthcare conference. During this significant event, co-founder and CEO, Neil Kumar, Ph.D., will take center stage to share insights into the...

Continue Reading
Experience the Artistry of the Sistine Chapel in Austin

Updated Category News Views 197

The Unveiling of the Sistine Chapel Experience in Austin Prepare to embark on an extraordinary journey through art and culture with the grand reveal of The Sistine Chapel Experience. This captivating digital reconstruction of Michelangelo's monumental frescoes brings the exquisite details of this historical masterpiece to life like never before. Located at the Barton...

Continue Reading
Aurora Spine Launches Innovative AERO™ Lumbar Fusion System

Updated Category News Views 148

Aurora Spine Introduces the AERO™ Lumbar Fusion System Aurora Spine Corporation has taken a significant step forward in the realm of spinal health solutions with the announcement of surgeries using its newly launched AERO™ Lumbar Fusion System. The initial surgeries were conducted by both an orthopedic surgeon and an interventionalist, marking a crucial milestone in...

Continue Reading
Pyxis Oncology Advances PYX-201 Trials for Cancer Treatment

Updated Category News Views 166

Exciting Developments at Pyxis Oncology In the realm of oncology, advancements in treatment options can spark hope for many patients facing difficult diagnoses. Pyxis Oncology, Inc., a company at the forefront of next-generation cancer therapies, has recently announced exciting progress in their clinical trials featuring PYX-201. This innovative drug represents potential...

Continue Reading
Skanska Secures Major Surgery Center Contract with Sutter Health

Updated Category News Views 371

Skanska's New Contract with Sutter Health Skanska has successfully signed a significant contract with Sutter Health to develop an ambulatory surgery center and a specialty clinic. This project holds a contract value of USD 55 million, approximately SEK 600 million, and it will positively impact the order bookings in the US for early 2025. Project Overview and Features The...

Continue Reading